Chr. Olesen Synthesis Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $11.3M
Latest Deal Amount
  • Investors
  • 1

Chr. Olesen Synthesis General Information

Description

Manufacturer of active pharmaceutical ingredients (APIs) and advanced intermediates designed to produce controlled substances comprising semi-synthetic opioids. The company is focused on controlled substances and molecules like Buprenorphine, Codeine Phosphate, Dexamfetamine, Hydromorphone and Lisdexamfetamine and also offers an election of other APIs like Pramipexole, Risedronate, Terbinafine and Tolfenamic Acid as well as advanced intermediates, enabling pharmaceutical clients to avail advanced intermediates and APIs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Primary Office
  • Kanalholmen 8-12
  • 2650 Hvidovre
  • Denmark
+45 36 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Chr. Olesen Synthesis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 01-Oct-2015 $11.3M 000.00 Completed Generating Revenue
To view Chr. Olesen Synthesis’s complete valuation and funding history, request access »

Chr. Olesen Synthesis Executive Team (3)

Name Title Board Seat Contact Info
Thomas Moestrup Chief Executive Officer
Erik Fischer Head, API Development
Lone Nielsen Finance & Administration Manager
To view Chr. Olesen Synthesis’s complete executive team members history, request access »

Chr. Olesen Synthesis Board Members (2)

Name Representing Role Since
James Gale Signet Healthcare Partners Board Member 000 0000
Mads Olesen Chr. Olesen Synthesis Chairman 000 0000
To view Chr. Olesen Synthesis’s complete board members history, request access »

Chr. Olesen Synthesis Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Signet Healthcare Partners Growth/Expansion Minority 000 0000 000000 0
To view Chr. Olesen Synthesis’s complete investors history, request access »

Chr. Olesen Synthesis Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 01-Jan-2011 000000000 Distributors (Healthcare)
To view Chr. Olesen Synthesis’s complete investments history, request access »

Chr. Olesen Synthesis Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 01-Jan-2011 000000000 Completed
  • 2 buyers
To view Chr. Olesen Synthesis’s complete exits history, request access »